Clinical Trial Update: Beta- Probe and Surgery in GEP NET: Evaluation of a New Probe [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating beta-probe and surgery in neuroendocrine tumors has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroendocrine Tumors

Snippet

Sponsor: European Institute of Oncology | Conditions: Neuroendocrine Tumors | Phase 2 | Status: COMPLETED